Ethan is a PhD candidate at The Lambert Initiative for Cannabinoid Therapeutics. Their master’s thesis was on characterising minor phytocannabinoids at endocannabinoid channel TRPA1. They have expanded this research since to encompass a cannabinoid-analogue screening program and C. elegans models of healthy ageing and disease models of age related decline.

Dr. Zhizhen Wang is a research fellow in Lambert Initiative for Cannabinoid Therapeutics at University of Sydney. Zhizhen received her PhD in neuroscience from the University of Wollongong in 2023. Her research focuses on the exploring the potential benefits of cannabinoids on the ageing process using the Caenorhabditis elegans (C. elegans) and human cell models. As an early career researcher, she has already authored 11 papers, with 6 as the first author, garnering a total of 685 citations in the fields of ageing and cannabis. She has co-supervised three honors students and is currently mentoring one PhD student. She also contributes as a reviewer for leading ageing journals.

Dr Philip Chi Lip Kwok is a Senior Lecturer in Pharmaceutical Sciences in the School of Pharmacy, The University of Sydney. He obtained his Bachelor of Pharmacy degree with First Class Honours in 2002 from this Faculty. He became a registered pharmacist after one year of training in a community pharmacy. Dr Kwok then undertook his PhD studies on pharmaceutical aerosol electrostatics in the Faculty of Pharmacy at The University of Sydney and graduated in 2007. He was a research associate in the same group until August 2011 and became an assistant professor in the Department of Pharmacology and Pharmacy at The University of Hong Kong in September 2011. Dr Kwok returned to The University of Sydney as a Lecturer in Pharmaceutical Sciences at the end of July 2017. His research is in pulmonary drug delivery. He specialises in the engineering, physicochemical characterisation, and electrostatics of pharmaceutical aerosol formulations.